Home > Healthcare > Drug Device Combination > Therapeutic Systems > Demineralized Bone Matrix Market

Demineralized Bone Matrix Market Size

Report ID: GMI8338
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Demineralized Bone Matrix Market Size

Demineralized Bone Matrix Market size was valued at USD 832.8 million in 2023 and is estimated to grow at a CAGR of 4.9% from 2024 to 2032. Demineralized bone matrix (DBM) is a biologic material derived from human or animal bone tissue that has undergone a process to remove its mineral content, primarily calcium salts. DBM retains the structural integrity and biological properties of natural bone tissue, making it a valuable option in various medical applications, particularly in orthopedic and dental surgeries.

To get key market trends

Download Free Sample

The rising prevalence of orthopedic disorders has emerged as a significant public health concern worldwide. For instance, according to the World Health Organization (WHO), in July 2022, around 1.71 billion people were affected by musculoskeletal conditions worldwide. Therefore, there is an increasing demand for advanced treatments such as demineralized bone matrix in orthopedic surgeries to facilitate bone healing and reconstruction.

Furthermore, growing technological advancements in demineralized bone matrix are expected to propel the growth of the market in the forthcoming years. These include innovations such as bone growth stimulators, a USD 875.2 million industry in 2021. The increasing patient base is also a contributing factor to the market expansion.

Demineralized Bone Matrix Market Report Attributes
Report Attribute	Details
Base Year:	2023
Demineralized Bone Matrix Market Size in 2023:	USD 832.8 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	4.9%
2032 Value Projection:	USD 1.3 Billion
Historical Data for:	2018 - 2023
No. of Pages:	178
Tables, Charts & Figures:	221
Segments covered:	Product Type, Application, End-use, and Region
Growth Drivers:	Rising incidence of orthopedic disorders Increasing number of spinal fusion and dental surgeries Increasing patient base with growing population Technological advancements in the field of demineralized bone matrix
Pitfalls & Challenges:	High cost of demineralized bone matrix

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Demineralized bone matrix market size was USD 832.8 million in 2023 and is expected to register 4.9% CAGR from 2024-2032 owing to the rising prevalence of orthopedic disorders emerging, as a significant public health concern worldwide.

The gel segment recorded USD 112.1 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its ability to adhere to surrounding tissues and bone surfaces, thereby increasing the stability and longevity of the graft at site.

North America demineralized bone matrix industry reached USD 337.5 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a sophisticated healthcare infrastructure and rising prevalence of orthopedic conditions in the region.

Institut Straumann AG, Johnson & Johnson, Medtronic plc, RTI Surgical, Inc., Seaspine Holdings Corporation, Stryker Corporation, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc., are some of the major demineralized bone matrix companies worldwide.